Ptc Therapeutics Inc stock is traded at $65.67, with a volume of 1,231,853. It is down -4.78% in the last 24 hours and up +3.17% over the past month. PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Previous Close:
$68.97
Open:
$68.80
24h Volume:
1,231,853
Relative Volume:
0.89
Market Cap:
$5.49B
Revenue:
$1.73B
Net Income/Loss:
$682.64M
P/E Ratio:
8.49
EPS:
$7.74
Net Cash Flow:
$411.18M
1W Performance:
+1.88%
1M Performance:
+3.17%
6M Performance:
+0.97%
1Y Performance:
-8.50%
1-Day Range:
$65.45$69.59
1-Week Range:
$59.16$70.11
52-Week Range:
$58.80$90.87
Ptc Therapeutics Inc Stock (PTCT) Company Profile
Name
Ptc Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(908) 222-7000Address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS